We earn a commission from brands listed on this site. This influences the order and manner in which these listings are presented.
Advertising Disclosure

Unlocking Your Genetic Code: How DNA Tests Can Help Detect Breast Cancer Risks

Giulio Chiesa - Writer for Top10
A woman doctor doing a DNA test for detecting breast cancer risks.
A small saliva sample could unlock secrets about your health and potentially give you the upper hand against breast cancer threats.

DNA testing kits are changing the way we manage health risks, particularly in detecting diseases like breast cancer. I've witnessed firsthand how helpful these tests can be in spotting early signs of breast cancer risk and creating effective prevention strategies.

Research confirms that genetic testing is key in pinpointing mutations in genes linked to a higher risk of breast cancer. Let me explain how DNA testing works for detecting breast cancer risks and why it plays a vital role in personalized health care.

» Read this before taking a DNA test at home.

BRCA1 and BRCA2 Genetic Testing

BRCA1 and BRCA2 gene mutations have a strong link to breast cancer, but they're quite rare, affecting about 1 in 500 women in the US. Most genetic and ancestry tests, like 23andMe, check for these mutations to help determine your risk of developing breast cancer.

If you or your family has a history of breast cancer, or if you know these mutations are in your family, your doctor may suggest getting tested for BRCA mutations.

This evaluation is a crucial step in understanding your risk and planning accordingly. Remember, these tests don't tell you if you have or will definitely get breast cancer; they just show if your risk is higher.

Multi-Gene Panel Testing

If you've got a family history of non-BRCA breast cancer, your doctor may suggest multi-gene panel testing. This method examines a broader range of genes to give a more comprehensive assessment of your breast cancer risk.

The exact genes tested can change over time and vary between providers, as research in this area continuously evolves. However, some genes, like BRCA1/2, PALB2, PTEN, P53, STK11, and CDH1, are commonly included because they significantly increase your likelihood of developing breast cancer.

Given the complexity of multi-gene panel testing, it's crucial to have a specialist interpret the results. An expert can break down what the findings mean for you and help you make informed decisions about your health. They can explain what a higher genetic risk involves and go over possible preventive measures or monitoring strategies.

Breast Cancer Risk Assessments Beyond DNA Testing

Beyond DNA testing, there are other innovative, non-routine methods you can use to assess breast cancer risks. Here are three specialized tests that can provide critical insights into your health and complement your DNA test results.

Gail Model: Medical Assessment

The Gail Model, unlike genetic testing, is a special type of medical assessment aimed at predicting your risk of developing breast or ovarian cancer within the next 10 years. It doesn't analyze your genes. Instead, it uses statistical models that consider your family and personal health history.

This assessment takes into account factors such as your age, family history of cancer, and other personal health details to calculate a score. This computation provides an estimate of your odds of developing these diseases.

» New to genetic testing? Here's how to read and understand your DNA test results.

Oncotype DX Test: Genomic Test

The Oncotype DX genomic test is employed in the early stages of cancer treatment. It examines the activity level of certain genes in your tumor cells using a sample from your tumor biopsy.

The test then provides insights into your cancer's behavior, including its aggressiveness, likelihood of spreading (metastasis) or recurrence, and whether it has affected lymph nodes. It's especially useful in determining the most effective treatment plan.

The test evaluates 21 genes to predict the probability of cancer recurrence, generating scores from 0 to 100. This "recurrence score" varies with age, but a high score (26-100) generally suggests an increased risk of recurrence. In such cases, medical professionals may recommend chemotherapy to prevent the cancer from coming back.

MammaPrint: A Key Test for Early Stage Cancer

MammaPrint is another genomic test specifically designed for those with early-stage breast cancer. It works by screening 70 different genes associated with the risk of cancer recurrence or metastasis.

MammaPrint's analysis of these genes enables your health care team to make better-informed treatment decisions. Should the test reveal a high risk of recurrence, your doctors may suggest more intensive treatment options.

» DNA tests run deeper than you think. Here are 10 fascinating traits tied to genetics.

When to Consider a Genetic Test for Breast Cancer Risk Assessment

Your doctor may suggest a genetic test after using statistical models like the Gail or Oncotype DX models. While these assessments provide valuable insights, they're not infallible. A genetic test can offer a more detailed understanding of your breast cancer risk. Consider getting a DNA test for breast cancer risk if:

  • Your family (parents, siblings, or ancestors) has a history of breast, ovarian, or male breast cancer, particularly if diagnosed before age 50.
  • You have personally been diagnosed with any of these cancers, especially at a young age.
  • You developed a second, distinct cancer, not a recurrence of the first.
  • You are of Ashkenazi Jewish descent, as this group has a higher prevalence of BRCA mutations (1 in 40 women).

AI and Home DNA Tests: Transforming Your Health Care

AI integration in precision medicine and at-home DNA tests, such as Living DNA and AncestryDNA, is changing health care. These tools help pinpoint your genetic risk for diseases like breast cancer. AI enhances this by correlating your genetic data with your symptoms and lifestyle to provide improved diagnoses and treatment plans.

However, remember to collaborate with health care professionals, as these advancements are just one part of a broader strategy.

» Identify health risks at home with our best DNA tests.

Giulio Chiesa - Writer for Top10
Giulio Chiesa works at Boston University as a postdoctoral researcher. He holds a PhD in biomedicine and biophysics from the University of Barcelona. He's dedicated to exploring how synthetic biology and biophysics can help create new gene therapies.